Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bisphosphonates Combined With Vancomycin for Osteomyelitis
NCT07435051Phase 3Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- May 2026
- Primary completion
- Dec 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of alendronate in osteomyelitis (OM) (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Infection control rate at 6 months. Planned start May 2026; status: not yet recruiting.
02
Drugs
alendronate
03
Conditions
osteomyelitis (OM)
Beyond the preview
Go deeper on NCT07435051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07435051.